0
Clinical and Research News
Medications Included in Study
Psychiatric News
Volume 41 Number 21 page 23-23

Participants in the British study comparing first-generation antipsychotics (FGAs) with second-generation antipsychotics (SGAs) were randomized to receive either an FGA or an SGA.

FGAs used in the trial:

  • chlorpromazine

  • flupenthixolFN1

  • haloperidol

  • loxapine

  • methotrimeprazineFN1

  • sulpirideFN1

  • trifluoperazine

  • zuclopenthixolFN1

  • fluphenazine decanoate

  • flupentixol decanoateFN1

  • haloperidol decanoate

  • pipothiazine palmitateFN1

  • zuclopenthixol decanoateFN1

    +
  • chlorpromazine

  • flupenthixolFN1

  • haloperidol

  • loxapine

  • methotrimeprazineFN1

  • sulpirideFN1

  • trifluoperazine

  • zuclopenthixolFN1

  • fluphenazine decanoate

  • flupentixol decanoateFN1

  • haloperidol decanoate

  • pipothiazine palmitateFN1

  • zuclopenthixol decanoateFN1

  • *

    Products not available in the United States.

    Products not available in the United States.

    Thioridazine hydrochloride and droperidol were also included initially but were withdrawn from licensed use during the trial.

    SGAs used in the trial:

    • risperidone

    • olanzapine

    • quetiapine

    • amisulprideFN1

    • zotepineFN1

      +
  • risperidone

  • olanzapine

  • quetiapine

  • amisulprideFN1

  • zotepineFN1

  • Interactive Graphics

    Video

    NOTE:
    Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
    Related Articles
    Articles